2016 ASH Meeting on Hematologic Malignancies
Description
Access recorded “How I Treat” presentations and topic-based panel discussions from the 2016 ASH Meeting on Hematologic Malignancies. Hear the top experts in the field discuss the latest developments in clinical care, showcase their evidence-based treatment approaches, and provide answers to challenging patient care questions.
Pricing
| Member Type | Price |
|---|---|
| List Price | $275.00 |
| Active, International, Emeritus, and Honorary Members | $100.00 |
| Associate, International Associate, Student, and Resident Members | $75.00 |
Sessions
Education Program
- Welcome and Opening Remarks (Day 1)
- How I Treat Hodgkin Lymphoma
- How I Treat Follicular Lymphoma
- How I Treat Mantle Cell Lymphoma
- Lymphoma Panel Discussion I
- How I Treat Low Grade MDS
- How I Treat High Grade MDS
- MDS Panel Discussion
- How I Treat Myelofibrosis Patients Who Have “Failed” Ruxolitinib
- How I Treat High-Risk Patients with Essential Thrombocythemia or Polycythemia Vera
- How I Treat MPN or CML: Who and When Am I Transplanting?
- MPN Panel Discussion
- How I Treat CLL
- How I Treat CLL: High-Risk Genetics
- CLL Panel Discussion
- Welcome and Opening Remarks
- How I Treat Hypocellular MDS
- How I Treat Relapsed AML: Do Molecular Genetics Help?
- MDS/AML Panel Discussion
- How I Treat ALL in First Complete Remission: Role of MRD and Molecular Genetics in Treatment Decisions
- How I Treat ALL in Older Adults: Ph+ and Ph- ALL
- ALL Panel Discussion
- How I Treat Diffuse Large B-Cell and Mediastinal Large Cell Lymphomas
- How I Treat Highly Aggressive Lymphomas: Burkitt, Double-Hit, B-Cell, and Unclassifiable with Features Intermediate between DLBCL and Burkitt Lymphoma
- Lymphoma Panel Discussion II
- How I Treat Myeloma Using Genomic Analysis
- How I Treat Newly Diagnosed Multiple Myeloma
- How I Treat Relapsed/Refractory Myeloma Including Novel Agents
- Myeloma Panel Discussion
- Closing Remarks and Adjournment
Highlights of ASH
Learn how new clinical research presented at the latest
ASH annual meeting will influence hematology patient care.
ASH Meeting on Hematologic Malignancies
Hear the latest developments in clinical care, and get answers to your most challenging patient care questions.
Learn more
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
Copyright © 2019 by American Society of Hematology